US regulators lead public-private trial 'master protocol' for antibiotics
This article was originally published in SRA
Executive Summary
"Bringing new antibiotics to market is going to require collaboration and co-operation on the part of everyone involved in the drug discovery and development processes," Francis Collins, director of the National Institutes of Health said at a US forum on how to revamp the antibiotics research and development enterprise1,2.